GlaxoSmithKline (NYSE: GSK) announced ARNUITY™ ELLIPTA ^® (fluticasone furoate dry powder for oral inhalation) has been approved in Canada as ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE